Correspondingly, in p53-impaired conditions, either caused by the expression of a p53 loss-of-function variant or ablation of P14ARF, β-catenin regains its oncogenic effects and is able to drive carcinogenesis, most notably in colorectal cancer [116,117]. Here, TP53 is linked to colorectal cancer.